KATIE GEISER: Open Payments
NPI 1013648591 · APPLETON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$257 in 13 payments from 8 companies in 2025. Trend: 2023 $681 · 2024 $533 · 2025 $257
Food & beverage: $257
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Boston Scientific Corporation | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $22 |
| Lilly USA, LLC | 1 | $14 |
Products named: REPATHA, ELIQUIS, LEQVIO, WATCHMAN Access System, ONPATTRO, CARDIOMEMS, SAPIEN 3 Ultra RESILIA, MOUNJARO.
Industry payments across WI — which companies pay providers there.
